carmustine has been researched along with Hand-Schu00FCller-Christian Disease in 2 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adult Langerhans cell histiocytosis (LCH) usually follows a favorable course." | 1.38 | [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transp ( Adam, Z; Adamová, Z; Brejcha, M; Hájek, R; Kodet, R; Koukalová, R; Krejčí, M; Mayer, J; Moulis, M; Nebeský, T; Pour, L; Rehák, Z; Szturz, P; Zahradová, L, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paris, A | 1 |
| Dib, M | 1 |
| Rousselet, MC | 1 |
| Urban, T | 1 |
| Tazi, A | 1 |
| Gagnadoux, F | 1 |
| Adam, Z | 1 |
| Rehák, Z | 1 |
| Koukalová, R | 1 |
| Szturz, P | 1 |
| Krejčí, M | 1 |
| Pour, L | 1 |
| Zahradová, L | 1 |
| Moulis, M | 1 |
| Kodet, R | 1 |
| Nebeský, T | 1 |
| Brejcha, M | 1 |
| Adamová, Z | 1 |
| Hájek, R | 1 |
| Mayer, J | 1 |
2 other studies available for carmustine and Hand-Schu00FCller-Christian Disease
| Article | Year |
|---|---|
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].
Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmusti | 2011 |
[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transp
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cladribine; Combined Modality The | 2012 |